Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Stressed women more likely to develop obesity

The more traumatic events a woman experiences during her lifetime, the more likely she is to become obese, researchers reported at the American Heart Association’s Scientific Sessions this week.

Thumbnail

Consumption of nuts may cut risk of heart disease by 20%

People who regularly eat nuts have a reduced risk of cardiovascular disease (CVD) and coronary heart disease (CHD) when compared to people who rarely or never eat nuts, according to a study published Nov. 13 in the Journal of the American College of Cardiology.

Thumbnail

A, B, AB blood types at increased risk for heart attack in high pollution

Cardiac patients whose blood type is A, B or AB are at increased risk for myocardial infarction (MI) in highly polluted environments, according to research out of two Utah medical centers.

Thumbnail

Innovations in heart tech: 5 things standing between now and better medical technology

From pocket-sized electrocardiograms to watches that measure blood glucose levels, the field of medical technology is rapidly evolving. But these innovations, though oftentimes successful, aren’t necessarily living up to what scientists want them to be, according to presenters at the American Heart Association’s Scientific Sessions 2017.

Thumbnail

Proving the cost-effectiveness of TAVR

When it comes to TAVR, what is good for patients is good for economics too. Or more specifically, what is good for Medicare patients with severe aortic stenosis at intermediate risk for surgery is good for reductions in U.S healthcare costs. The amount depends on where you live, with CMS reimbursing much higher on the East and West Coasts versus the center of the country with valve costs remaining the same.

Jardiance® reduced risk of cardiovascular death in adults with type 2 diabetes and peripheral artery disease

RIDGEFIELD, Conn. and INDIANAPOLIS, Nov. 13, 2017 — New data presented today showed that Jardiance® reduced the risk of cardiovascular death compared with placebo when added to standard of care in adults with type 2 diabetes and peripheral artery disease.

New Analyses Presented At AHA 2017 Show Repatha® (evolocumab) Significantly Reduced Cardiovascular Events In Patients With Peripheral Artery Disease And In Patients With A History Of Heart Attacks

THOUSAND OAKS, Calif., Nov. 13, 2017 — Amgen (NASDAQ:AMGN) today announced five new subgroup analyses from the Repatha® (evolocumab) cardiovascular outcomes study (FOURIER) that showed the addition of Repatha to statin therapy improved clinical outcomes with significant reduction of cardiovascular (CV) events, such as heart attack (also called myocardial infarction or MI) and stroke, in high-risk patients with peripheral artery disease (PAD), and in patients with a history of heart attack.

AHA, ACC lower bar for high blood pressure; 46% of US adults now have hypertension

In the first update to U.S. guidelines on blood pressure in 14 years, a writing committee changed the definition of high blood pressure from 140/90 millimeters of mercury or higher to 130/80 or higher.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.